France· FR:66751955
CARTEOL L.P. 1 %, collyre à libération prolongée en récipient unidose
A medicinal product containing chlorhydrate de cartéolol, registered in France by LABORATOIRE CHAUVIN, on the national reimbursement list.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- CHLORHYDRATE DE CARTÉOLOL
- Manufacturer
- LABORATOIRE CHAUVIN
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- cip13340093600663830 récipient(s) unidose(s) polyéthylène basse densité (PEBD) de 0,2 mlEUR 6.42
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Chlorhydrate de cartéolol in 11 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomCarteolol 1% eye dropsDE Pharmaceuticals
- Japanカルテオロール塩酸塩東亜薬品
- BelgiumArteoptic LA 1 %Bausch & Lomb Pharma
- ItalyCARTEABAK*collirio 5 ml 1%LABORATOIRES THEA
- SpainARTEOPTIC 1% COLIRIO DE LIBERACION PROLONGADABausch + Lomb Ireland Limited
- PolandCarteol LP 2%Medezin Sp. z o.o.
- SwitzerlandArteoptic LA
- NetherlandsArteoptic zonder conserveermiddel 20 mg/ml, oogdruppels, oplossing met verlengde afgifteBausch + Lomb Ireland Limited
Authorised across Europe · EMA
The same active substance is authorised in 11 EEA countries. Names it is sold under:
- Belgium · Arteoptic La, Arteoptic La Sine Conservans
- Czechia · Carteol Lp, Carteol Neo
- Spain · Arteoptic, Arteoptic Pf
- Croatia · Cartelomb
- Italy · Carteabak, Carteol
- Luxembourg · Arteoptic La, Arteoptic La Sine Conservans
- Netherlands · Arteoptic Zonder Conserveermiddel, Carteabak
- Poland · Carteol Lp, Carteol Lp Preservative Free
- Portugal · Physioglau, Physioglau Pf
- Slovenia · Cartelomb
- Slovakia · Carteol Lp, Carteol Neo
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b77e09cd-9db1-4d0d-b9b1-190828344b4d GET /v1/drugs/b77e09cd-9db1-4d0d-b9b1-190828344b4d?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "66751955",
"date_amm": "2002-10-23",
"type_amm": "Procédure de reconnaissance mutuelle",
"numero_ue": null,
"substance": "CHLORHYDRATE DE CARTÉOLOL",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "collyre à libération prolongée",
"voies_administration": "ophtalmique",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about chlorhydrate de cartéolol.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.